November 26th, 2025: Ozempic and Mounjaro Litigation Expands Following New Evidence of Heightened GI Risks A newly released study has increased scrutiny of GLP-1 receptor agonists such as Ozempic, Mounjaro, and Trulicity, linking these medications to substantially higher rates of gastrointestinal complications than older diabetes treatments
Rodrigues, M., Ezzedine, K., Hamzavi, I., Pandya, A
The interaction between microorganisms, metabolites, and immune system in the female genital tract microenvironment
Because CBSI schedules only a few cases per day, patients often move from consult to operating room faster than at larger systems
Exp Clin Hepatol 7:710
Unrecognized diabetes can be unveiled during an episode of pancreatitis and is defined as elevated glycated HbA1c 6.5% above the diabetes diagnostic threshold, first detected during the course of pancreatitis and/or within 3 mo after hospital admission[5]